Momenta Pharmaceuticals, Inc. (MNTA)

[flatlander_60048]

One of the things CW emphasized during the annual mtg was that the long term strategy for MNTA has always been to establish a revenue stream by introducing fully substitutable products via the ANDA pathway and then use the revenue stream for novel drug development. I think some of the hires show that MNTA is shifting some of the brainpower emphasis to novel new drug research.

FL